Shawn K. Singh
2016
In 2016, Shawn K. Singh earned a total compensation of $2M as Chief Executive Officer at Vistagen Therapeutics, a 91% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,629,574 |
|---|---|
| Salary | $347,500 |
| Total | $1,977,074 |
Singh received $1.6M in option awards, accounting for 82% of the total pay in 2016.
Singh also received $347.5K in salary.
Rankings
In 2016, Shawn K. Singh's compensation ranked 4,944th out of 14,075 executives tracked by ExecPay. In other words, Singh earned more than 64.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,944 out of 14,075 | 65th |
Division Manufacturing | 1,764 out of 5,489 | 68th |
Major group Chemicals And Allied Products | 556 out of 1,895 | 71st |
Industry group Drugs | 412 out of 1,538 | 73rd |
Industry Pharmaceutical Preparations | 327 out of 1,176 | 72nd |
Source: SEC filing on August 5, 2016.
Singh's colleagues
We found two more compensation records of executives who worked with Shawn K. Singh at Vistagen Therapeutics in 2016.